Indiana Clinical and Translational Sciences Institute

印第安纳临床与转化科学研究所

• 批准号: 9283643
• 负责人: Scott C. Denne
• 金额: $ 69.1万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-26 至 2018-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9283643
• 关键词: Award; Clinical Research; Clinical Sciences; Development; Environment; Evaluation; Health; Health Benefit; Health Personnel; Home environment; Human; Human Subject Research; Indiana; Institutes; Institution; Instruction; Leadership; Mission; Private Sector; Process; Research; Research Infrastructure; Research Personnel; Research Project Grants; Research Support; Research Training; Resources; Services; Structure; Technology; Testing; Training; Training Programs; Training and Education; Translational Research; Universities; Vision; career; career development; catalyst; empowered; improved; informatics infrastructure; innovation; novel; programs; public-private partnership; success; tool; translational scientist

The Indiana Clinical and Translational Sciences Institute (CTSI) was created in 2008 at the crest of a wave of transformation of the three research universities in Indiana and has become a flagship catalyst for the state's biomedical Initiatives. The mission of the Indiana CTSI is to be an integrated home for clinical and translational research that creates a shared, investigator-friendly Institutional environment and provides easily accessible resources, services, and training to conduct the highest-quality research dedicated to improving human health across Indiana and beyond. The Four Specific Aims of the Indiana CTSI are: Aim I. Implement an Indiana roadmap for building the ideal research environment and collaborative platforms to conduct innovative research using our excellent multi-institutional, public-private partnerships throughout the state of Indiana and beyond by bringing together all three major research universities, Indiana, Purdue and Notre Dame, the state's key health care provider partners, private sector and corporate entities, and local and state agencies to create the infrastructure. Aim II. Further develop our successful Indiana CTSI established with the previous award into an "integrated home" that supports the careers and research projects of translational scientists and trainees through a streamlined structure, empowered leadership and administration, coordinated partner institution resources,.robust informatics infrastructure, innovative project development teams, and continuous evaluation and process improvement Aim III. Promote utilization of our innovative services and a well-tested network of resources and technologies in order to catalyze high-quality, efficient, and safe clinical and translational research. We have created Project Assistance and Resources for Translational Scientists (PARTS) suite of both established and new research support services and resources, a statewide network of technology cores, and a coordinated human subject research services and facilities. Aim IV. Extend our success in statewide education and training of clinical and translational research workforce through our Career development. Education and Research Training (CERT) suite of programs that includes successful existing programs, new training programs, and novel educational tools. RELEVANCE (See instructions): The Indiana Clinical and Translational Sciences Institute (CTSI) was created in 2008 as a statewide institute by the partnership of three research universities in Indiana (Indiana, Purdue and Notre Dame) and has become an essential resource for the state's biomedical initiatives. Here we describe its innovative vision, its impact, and its success in creating public-private partnerships to benefit the health and economy of the state.

印第安纳州的临床和转化科学研究所（CTSI）于2008年创建 印第安纳州三所研究大学的转型，并已成为旗舰催化剂 州的生物医学计划。印第安纳州CTSI的使命是成为临床的综合之家 转化研究创造了共同的，调查员友好的机构环境，并提供 易于访问的资源，服务和培训，以进行专门的最高质量研究 改善印第安纳州及其他地区的人类健康。印第安纳州CTSI的四个具体目标是： AIM I.实施印第安纳州的路线图，以构建理想的研究环境和协作平台 使用我们始终的出色的多机构的公私合作伙伴关系进行创新研究 印第安纳州及以后 和巴黎圣母院，该州的主要医疗保健提供者合作伙伴，私营部门和公司实体，以及 本地和州机构创建基础架构。目标II。进一步发展我们成功的印第安纳州CTSI 以先前的奖项成立为“综合房屋”，以支持职业和研究 转化科学家和学员的项目通过简化的结构，授权领导能力和 行政，协调合作机构资源，。抛光信息学基础架构，创新项目 开发团队，以及持续的评估和过程改进目标III。促进我们的利用 创新服务以及经过良好的资源和技术网络，以促进高质量 高效，安全的临床和转化研究。我们为项目援助和资源创造了 建立和新研究支持服务的转化科学家（零件）套件以及 资源，全州核心网络以及协调的人类学科研究服务和 设施。目标IV。扩展我们在全州教育和临床和翻译培训方面的成功 通过我们的职业发展研究员工。教育与研究培训（CERT）套件 包括成功现有计划，新培训计划和新颖的教育工具的计划。 相关性（请参阅说明）： 印第安纳州临床和转化科学研究所（CTSI）于2008年创建为州立机构 通过印第安纳州（印第安纳州，普渡大学和巴黎圣母院）的三所研究大学的合作伙伴关系 成为该州生物医学计划的重要资源。在这里，我们描述了它的创新愿景 影响及其在建立公私伙伴关系方面的成功以使国家的健康和经济受益。

项目成果

Mild vs. moderate: How behavioral speech measures predict metacognitive capacity across different levels of formal thought disorder.

轻度与中度：行为言语测量如何预测不同程度的正式思维障碍的元认知能力。

• DOI: 10.1016/j.jpsychires.2022.11.013
• 发表时间: 2023
• 期刊: Journal of psychiatric research
• 影响因子: 4.8
• 作者: Myers,EvanJ;Abel,DanielleB;Hardin,KathrynL;Bettis,RobertJ;Beard,AshlynnM;Salyers,MichelleP;Lysaker,PaulH;Minor,KyleS
• 通讯作者: Minor,KyleS

Harvest tissue source does not alter the protective power of stromal cell therapy after intestinal ischemia and reperfusion injury.

• DOI: 10.1016/j.jss.2016.05.006
• 发表时间: 2016-08
• 期刊: JOURNAL OF SURGICAL RESEARCH
• 影响因子: 2.2
• 作者: Jensen, Amanda R.;Manning, Morenci M.;Khaneki, Sina;Drucker, Natalie A.;Markel, Troy A.
• 通讯作者: Markel, Troy A.

Leveraging Social Networking Sites for an Autoimmune Hepatitis Genetic Repository: Pilot Study to Evaluate Feasibility.

• DOI: 10.2196/jmir.7683
• 发表时间: 2018-01-18
• 期刊: Journal of medical Internet research
• 影响因子: 7.4
• 作者: Comerford M;Fogel R;Bailey JR;Chilukuri P;Chalasani N;Lammert CS
• 通讯作者: Lammert CS

Quality versus quantity: Determining real-world social functioning deficits in schizophrenia.

• DOI: 10.1016/j.psychres.2021.113980
• 发表时间: 2021-07
• 期刊: Psychiatry research
• 影响因子: 11.3
• 作者: Abel DB;Salyers MP;Wu W;Monette MA;Minor KS
• 通讯作者: Minor KS

Social functioning in schizophrenia: Comparing laboratory-based assessment with real-world measures.

• DOI: 10.1016/j.jpsychires.2021.04.039
• 发表时间: 2021-06
• 期刊: Journal of psychiatric research
• 影响因子: 4.8
• 作者: Abel DB;Minor KS
• 通讯作者: Minor KS